Softwr

Healthcare · head to head

Koa Health vs PathAI

Koa Health logo

Koa Health

Healthcare

Employer and health plan digital mental health, acquired by PsychPlus in June 2026

From
On request
Rated
-
PathAI logo

PathAI

Healthcare

Digital pathology image management with an FDA cleared platform for primary diagnosis

From
On request
Rated
-

The short version

  • Each has a real cost: Koa Health psychPlus acquired Koa Health in June 2026, so buyers are now contracting with the technology arm of an American psychiatry provider group rather than a European digital health company, and roadmap, data residency and European product investment should all be re-examined before renewal.; PathAI aISight is labelled research use only and cannot be used for primary diagnosis; only AISight Dx carries the FDA clearance and CE-IVD mark, and laboratories regularly buy the wrong configuration and discover they cannot sign out on it.
  • They diverge on capability: Koa Health covers Stepped care triage, PathAI covers AISight image management.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which Koa Health and PathAI actually diverge.

Attributes where Koa Health and PathAI differ
AttributeKoa HealthPathAI
PlatformsWeb, iOS, AndroidWeb

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Koa Health

  • Stepped care triage
  • Self guided digital modules
  • Coaching tier
  • Licensed clinical care
  • Employer and plan reporting
  • Multi country delivery
  • Clinical governance

Only in PathAI

  • AISight image management
  • AISight Dx
  • Scanner interoperability
  • Case and worklist management
  • AI algorithm deployment
  • Biopharmaceutical research tooling
  • LIS integration

What people use each for

The jobs each tool is most often brought in to do.

Koa Health

  • An employer that wants something between a meditation app and a full clinical benefit, with triage deciding which members need a cliniciannot PathAI
  • A European health plan needing a digital mental health offering with clinical governance and local language deliverynot PathAI
  • A health system wanting to absorb low acuity behavioural health demand before it reaches scarce psychiatry appointmentsnot PathAI
  • A multinational standardising a stepped care pathway across several European markets under one contractnot PathAI

PathAI

  • An academic medical centre going digital for primary diagnosis that needs the FDA cleared AISight Dx configuration rather than the research labelled versionnot Koa Health
  • A reference laboratory consolidating subspecialty sign out across sites so a specialist pathologist can read cases from any locationnot Koa Health
  • A pharmaceutical company needing consistent quantitative scoring of trial biopsies across many sites and readersnot Koa Health
  • A laboratory with a mixed scanner estate that needs one image management layer rather than each scanner vendor viewernot Koa Health

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Koa Health

  • PsychPlus acquired Koa Health in June 2026, so buyers are now contracting with the technology arm of an American psychiatry provider group rather than a European digital health company, and roadmap, data residency and European product investment should all be re-examined before renewal.
  • Stepped care only produces savings when triage is accurate, and members routed to a self guided module when they believe they need a therapist commonly disengage entirely, which a utilisation report records as low engagement rather than as a triage failure.
  • Pricing is per employee or per member per month across the eligible population, so an employer with modest engagement pays for everyone in order to serve a minority.
  • Clinician availability and language coverage differ substantially by country, so a multinational contract that reads as one global standard delivers a materially different experience in secondary markets.
  • Koa competes against much larger and better funded benefits vendors in the United States, and the acquisition does not change the fact that its brand recognition with American benefits consultants is low, which affects broker driven shortlists.

PathAI

  • AISight is labelled research use only and cannot be used for primary diagnosis; only AISight Dx carries the FDA clearance and CE-IVD mark, and laboratories regularly buy the wrong configuration and discover they cannot sign out on it.
  • The software licence is usually the smallest line in a digital pathology project, behind scanners, storage and network capacity, so a business case built around the software cost understates the real investment by a wide margin.
  • Whole slide images are very large, so a laboratory that does not model storage growth and retention policy from the start faces storage costs that grow faster than case volume and dominate the renewal.
  • Clinical validation is required per subspecialty rather than once for the platform, which means dermatopathology, gastrointestinal and breast each need their own concordance study and pathologist time before go live.
  • PathAI competes against pathology incumbents that also sell the scanners, and a laboratory buying an independent image management layer takes on the integration risk between scanner vendor and software vendor itself.

Pricing, plan by plan

Koa Health

On request
  • Koa Health$undefined/year
    • Per employee per month or per member per month, quoted not published
    • Rate depends on which steps of the care ladder are included
    • Clinical tier access priced separately from digital content access

PathAI

On request
  • AISight$undefined/year
    • Priced by annual slide or case volume and by pathologist seats
    • AISight Dx, the clinically cleared configuration, quoted separately from research use AISight
    • Image storage priced by capacity and retention policy

Which should you pick?

Choose Koa Health if

  • You need stepped care triage.
  • You work on Web, iOS, Android.
  • You also want self guided digital modules.

Choose PathAI if

  • You need aisight image management.
  • You also want aisight dx.

Questions people ask

Is Koa Health or PathAI better?
Neither clearly leads. Koa Health starts at On request and PathAI at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Koa Health or PathAI?
Koa Health starts at On request and PathAI at On request.
Does Koa Health or PathAI run on more platforms?
Koa Health runs on Web, iOS, Android. PathAI runs on Web.
What is Koa Health best used for?
Koa Health is most often used for an employer that wants something between a meditation app and a full clinical benefit, with triage deciding which members need a clinician, a european health plan needing a digital mental health offering with clinical governance and local language delivery, a health system wanting to absorb low acuity behavioural health demand before it reaches scarce psychiatry appointments, a multinational standardising a stepped care pathway across several european markets under one contract. Of those, an employer that wants something between a meditation app and a full clinical benefit, with triage deciding which members need a clinician and a european health plan needing a digital mental health offering with clinical governance and local language delivery are not what PathAI is typically brought in for.
What can Koa Health do that PathAI cannot?
Koa Health covers Stepped care triage, Self guided digital modules, Coaching tier, Licensed clinical care. PathAI covers AISight image management, AISight Dx, Scanner interoperability, Case and worklist management.

Answered from the vendors’ own pages

Koa Health: Is Koa Health still operating?

Yes. PsychPlus acquired it in June 2026 and the brand and platform continue. It is not a shutdown, but the ownership and clinical direction have changed.

PathAI: What is the difference between AISight and AISight Dx?

AISight is for research use only and not for clinical diagnostic use. AISight Dx received FDA 510(k) clearance in June 2025 for primary diagnosis and is CE-IVD marked in the EEA, UK and Switzerland. Only the Dx configuration can be used to sign out cases.

Koa Health: Who buys Koa Health?

Employers, health plans and health systems. It is not sold direct to individuals.

PathAI: Can we use our existing scanners?

Yes. AISight is designed to ingest images from multiple whole slide scanner vendors, which is one of the main reasons laboratories choose an independent image management layer.

Koa Health: How is it priced?

Per employee or per member per month, quoted rather than published, with the rate depending on which steps of the care ladder are in scope.

PathAI: Do the AI algorithms carry the same clearance as the platform?

No. The platform clearance covers image management for primary diagnosis. Individual algorithms have their own labelling, and many are research use only. Check each one separately.

Koa Health: Does it provide access to psychiatrists?

Clinical access is included in the higher tiers, and the PsychPlus acquisition adds psychiatry provider capacity in the United States. Confirm what your specific contract covers.

PathAI: Is pricing published?

No. It is quoted by slide or case volume, pathologist seats and storage, with the clinically cleared configuration priced separately.

Share

Related pages

Other head to heads